Mannitol promotes the apoptosis ofhuman lung squamous carcinoma cell line NCI-H292

doi:10.16352/j.issn.1001-6325.2025.03.0336

Abstract

Abstract: Objective To investigate the effects of 20% mannitol injection on the proliferation and apoptosis of human lung squamous carcinoma cell line NCI-H292 and its possible mechanisms. Methods NCI-H292 cells were incubated with 20% and lower concentrations of mannitol. Cell proliferation and viability were detected by CCK-8 assay. Cell apoptosis was detected by flow cytometry and the expression of mitochondrial apoptosis pathway-related proteins Bcl-2 and Bax was detected by Western blot. Results Compared with the control group, mannitol inhibited cell proliferation in a dose- and time-dependent manner (P＜ 0.05), 20% mannitol could induce cell apoptosis (P＜ 0.05). The expression level of Bcl-2 was significantly reduced, while that expression level of Bax was significantly increased in cells incubated with 20% mannitol (P＜ 0.05). Conclusions Clinically used 20% mannitol injection can induce apoptosis of lung squamous carcinoma cell line NCI-H292. Its mechanism is related to mitochondrial pathway-related proteins Bcl-2 and Bax.

Key words: mannitol, lung squamous cell carcinoma, apoptosis, Bcl-2, Bax

CLC Number:

R73-36
R982

LI Huangyi, HUANG Daohang, ZHANG Wenyu, HUANG Dingming, HUANG Qichun. Mannitol promotes the apoptosis ofhuman lung squamous carcinoma cell line NCI-H292[J]. Basic & Clinical Medicine, 2025, 45(3): 336-340.

References

[1] 黄鼎铭,谢彤,崔英,等.20%甘露醇治疗癌性胸水的临床研究(简报)[J]. 广西医科大学学报,2007,24:144-144.
[2] 李黄羿,黄鼎铭.特定浓度甘露醇对SPC-A-1人肺癌细胞的凋亡实验研究[J]. 基层医学论坛,2022,26:1-3+7.
[3] Liang Q, Gong M, Zou JH, et al. A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma[J]. Drug Resist Updat, 2023;68:100957.doi:10.1016/j.drup.2023.100957.
[4] Chiari R, Palladino S, Emili R, et al. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocar-cinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab[J]. Sci Rep, 2023,13:21036.doi:10.1038/s41598023-48304-0.
[5] Gong J, Gu J, Jiang L, et al. Clinical study on the efficacy of bevacizumab in combination with pembrolizu-mab on cellular immune function in the treatment of driver gene-negative stage Ⅳ lung adenocarcinoma[J]. J Oncol, 2022,2022:7298192.doi:10.1155/2022/7298192.
[6] Wang Y, Liu C, Chen H, et al. Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma[J]. Signal Transduct Target Ther, 2024,9:153.doi:10.1038/s41392-024-01875-4.
[7] Lim SM, Kang SS, Kim DK, et al. Exploration of immune-modulatory effects of amivantamab in combina-tion with pembrolizumab in lung and head and neck squamous cell carcinoma[J]. Cancer Res Commun, 2024,4:1748-1764.
[8] Ren K, Peng Q, Ding G, et al. Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma[J]. Immunotherapy, 2022,14:15-21.
[9] Jiang W, Zhou Y, Zeng L, et al. The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoad-juvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study[J]. Transl Lung Cancer Res, 2022,11:647-655.
[10] Tang L, Liu J, Zhu L, et al. Curcumin inhibits growth of human NCI-H292 lung squamous cell carcinoma cells by increasing FOXA2 expression[J]. Front Pharmacol, 2018,9:60.doi:10.3389/fphar.2018.00060.
[11] 程继,付国,赵华才,等.姜黄素提高人前列腺癌细胞系PC-3放疗敏感性[J]. 基础医学与临床,2021,41:1792-1796.
[12] 于振刚,王炳辙,孙开宇.肺鳞癌中Bcl-2、Bax蛋白的表达与细胞凋亡的临床意义[J]. 当代医学,2011,17:10-12.

[1]	SHEN Hongmei, YU Yan, FENG Xuqiang, WANG Keqiang. Usnea acid inhibits the proliferation of human ovarian cancer cell line [J]. Basic & Clinical Medicine, 2025, 45(1): 31-37.
[2]	ZHANG Wenqian, ZHOU Yue, REN Weidong, TONG Anli. Effects of curcumin on the proliferation and invasiveness of pheochromocytoma cell line PC12 [J]. Basic & Clinical Medicine, 2025, 45(1): 38-43.
[3]	LUO Menglin, ZHENG Feng, JI Xinyao, QI Caihong, XIAO Yuheng, NIU Changchun. Fluid shear promotes apoptosis of glomerular endothelial cells by activation of Piezo 1 [J]. Basic & Clinical Medicine, 2024, 44(9): 1236-1242.
[4]	ZHOU Changdong, LIN Yang, SUN Kai, TIAN Yuxin. Knockdown of lncRNA UCA1 reduces gemcitabine resistance of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2024, 44(8): 1113-1119.
[5]	WANG Tingting, WEI Huan, YANG Yongli, ZHOU Xian, HU Yang. Nervous protection provided by notoginsenoside Rg1 in rat model with Alzheimer′s disease [J]. Basic & Clinical Medicine, 2024, 44(8): 1094-1100.
[6]	GAO Chao, ZHANG Runhan, WANG Wei, ZHAO Manting, JIAO Yan, LI Zhe. Effect of artesunate on neuroinflammation in depressed mouse model by regulating cGAS-STING signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(8): 1126-1132.
[7]	YU Dongling, MO Shaoe, FU Wen, CHEN Shi, XIE Chouqin, LAN Yuyan. Inhibition of sigma-1 receptor reduces DRG cell apoptosis of rats with neuropathic pain [J]. Basic & Clinical Medicine, 2024, 44(8): 1101-1106.
[8]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[9]	LI Jinping, LIU Hanqing, YANG Quanhui. Change of cell cycle in rat spleen after severe abdominal infection [J]. Basic & Clinical Medicine, 2024, 44(6): 828-832.
[10]	GONG Jintao, LI Jianwei, LI Yuheng, LI Qian, ZHAO Chunhua. Bone marrow-derived mesenchymal stem cells relieve the adverse effects of simulated microgravity on mouse cerebral cortex [J]. Basic & Clinical Medicine, 2024, 44(6): 772-778.
[11]	YANG Chunsheng, WANG Tianxing, ZHANG Tiecheng, WU Hengmin, WANG Baolan. Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes [J]. Basic & Clinical Medicine, 2024, 44(4): 496-502.
[12]	YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
[13]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[14]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[15]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.